Dexcom (DXCM)

SG&A Expense Growth

2.57%

Quarterly · Period ending:

DXCM logo

DXCM SG&A Expense Growth

Latest reported2.57%
DXCM Quarterly SG&A Growth (QoQ) (0.00% → 2.57%)
High-resolution chart · PNG

DXCM sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Dexcom SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
2.5736%
8.7714%
-2.9873%
1.0366%
5.7723%
-5.2841%
6.8538%
-7.905%
4.1967%
3.4003%
7.8212%
-4.214%
0.8772%
-0.4701%
26.9395%
-5.7453%
13.7049%
-6.8907%
18.4383%
6.4343%
-1.1135%
7.22%
10.9079%
16.2757%
-8.9453%
16.124%
3.8647%
-10.1952%
11.3527%
10.7939%
7.1702%
-6.0198%
6.2023%
12.931%
10.2138%
-1.8648%
-0.6944%
9.2288%
4.4914%
9.2352%
11.5942%
1.6367%
16.826%
15.708%
14.7208%
8.8398%
7.4184%
9.0615%
11.9565%
15.9664%
10.1852%
4.3478%
14.3646%
5.2632%
13.5583%
-1.637%
2.1567%
9.6964%
3.7459%
8.1428%
14.2377%
7.4702%
-3.8932%
0.1448%
5.7995%
4.2248%
5.0179%
-0.0447%
13.2734%
7.5384%
10.4781%
-8.2103%
12.864%
13.5857%
-4.8797%
8.667%
1.8246%
2.0374%
-25.5876%
43.4155%
28.3987%
131.6008%
-8.7683%
-2.4388%
171.413%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.